SCHEMBL4593793

SCHEMBL4593793

O=C(O)[C@@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](NS(=O)(=O)O)[C@@H](O)O[C@@H]2COS(=O)(=O)O)[C@H](OS(=O)(=O)O)[C@@H](O)[C@@H]1O

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
F10 P00742 4/20 0.64
SERPINC1 P01008 2/20 0.46
F2 P00734 1/20 0.46
BDNF P23560 3/20 0.46
PTN P21246 2/20 0.46
MDK P21741 2/20 0.46
FGF1 P05230 2/20 0.42
FGF2 P09038 1/20 0.42
CXCL12 P48061 3/20 0.42
CCL2 P13500 2/20 0.42
CXCL10 P02778 1/20 0.42
CXCL8 P10145 1/20 0.42
CCL5 P13501 1/20 0.42
BMP2 P12643 2/20 0.38
VEGFA P15692 2/20 0.38
SHH Q15465 2/20 0.38
HPSE Q9Y251 6/20 0.38
PF4 P02776 2/20 0.37
IFNG P01579 1/20 0.37
SELP P16109 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13311345 1.00 F10 (0.64) F10SERPINC1F2BDNFPTN
SCHEMBL14670002 1.00 F10 (0.64) F10SERPINC1F2BDNFPTN
SCHEMBL15416845 0.91 F10 (0.57) F10SERPINC1F2BDNFPTN
SCHEMBL30006146 0.91 F10 (0.57) F10SERPINC1F2BDNFPTN
SCHEMBL23337007 0.90 F10 (0.64) F10SERPINC1F2BDNFPTN
SCHEMBL29308178 0.89 F10 (0.79) F10SERPINC1F2BDNFPTN
SCHEMBL23135895 0.89 F10 (0.62) F10SERPINC1F2BDNFPTN
SCHEMBL16509456 0.86 F10 (0.77) F10SERPINC1F2BDNFPTN
SCHEMBL15417563 0.85 F10 (0.53) F10SERPINC1F2BDNFPTN
SCHEMBL27448112 0.84 BDNF (0.60) F10SERPINC1F2BDNFPTN

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1942929-A2 HEPARAN SULFATE GLYCOSAMINOGLYCAN LYASE AND USES THEREOF Momenta Pharmaceuticals, Inc. (US) 2008-07-16 EP disclosed
WO-2007056218-A2 HEPARAN SULFATE GLYCOSAMINOGLYCAN LYASE AND USES THEREOF MOMENTA PHARMACEUTICALS, INC. (US) 2007-05-18 WO disclosed